Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
san diego blog main
san francisco blog main
startups
vertex pharmaceuticals
0
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
artificial intelligence
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
avrobio
biotech & health
bluebird bio
boston
boulder/denver blog main
boulder/denver top stories
brexanolone
business
camp4 therapeutics
cancer
cancer immunotherapy
crispr therapeutics
crispr-cas9
deals
denali therapeutics
detroit blog main
detroit top stories
drug
duchenne muscular dystrophy
What
drug
5
×
reach
5
×
clinical
stage
trials
years
advocates
ago
ahead
ambien
american
annual
arrive
asco
attendees
attention
backed
biotech
biotechs
camp’s
cancer
cash
chicago
city
combinations
community’s
considering
cornerstone
cost
costly
created
data
days
deemed
device
diseases
disprove
dyne
early
efficacy
Language
unset
Current search:
reach
×
drug
×
@techcrunch.com
8 months ago
Lindus Health, a U.K. clinical trials startup backed by Peter Thiel, raises $18M
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@mobilesyrup.com
4 years ago
AI-created medicine to be used in human trials for the first time
@engadget.com
4 years ago
A generic HIV prevention drug should arrive in 2021
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More